2014
DOI: 10.1016/j.neuropharm.2014.04.002
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Psychostimulant addiction treatment

Abstract: Treatment of psychostimulant addiction has been a major, and not fully met, challenge. For opioid addiction, there is strong evidence for the effectiveness of several medications. For psychostimulants, there is no corresponding form of agonist maintenance that has met criteria for regulatory approval or generally accepted use. Stimulant-use disorders remain prevalent and can result in both short-term and long-term adverse consequences. The mainstay of treatment remains behavioral interventions. In this paper, … Show more

Search citation statements

Order By: Relevance

Paper Sections

Select...
54
19
4
1

Citation Types

0
49
0
0

Year Published

Range
2014
2014
2026
2026

Publication Types

Select...
66
5
4
1

Relationship

0
76

Authors

Journals

citations

Cited by 76 publications

(49 citation statements)
references

References 126 publications

0
49
0
0
Order By: Relevance
How this paper cites the one you are viewing
“…The increased heart rate, blood pressure, and body temperature were occasionally accompanied with breathing difficulties, profuse sweating, and muscle tension. These effects, along with classic psychostimulant symptoms such as sleep deprivation and suppressed appetite, 14 give further support to the notion of ethylphenidate as a highly potent NPS. Another ordeal type of experience appeared to be the administration of the drug.…”
Section: Discussion
mentioning
confidence: 63%
“…The stimulating energy boost, euphoria, and increased self-confidence reported by the users were concordant with the characteristics of other potent psychostimulants such as amphetamine or cocaine. 14 Furthermore, the users stated that they were motivated by an increase in sociableness. Ethylphenidate acted as a social lubricant, enhancing intimacy, empathy, and communication.…”
Section: Discussion
mentioning
confidence: 99%
See 1 more Smart Citation